Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China

MLA

Zhi-Hong Zheng, et al. “Younger Patients with Chronic Lymphocytic Leukemia Benefit from Rituximab Treatment: A Single Center Study in China.” Oncology Letters, vol. 5, no. 4, Nov. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c5f6fac491dd6b3b5d89682943f393b1&authtype=sso&custid=ns315887.

APA

Zhi-Hong Zheng, Shun-Quan Wu, Rong Zhan, Jin-Yan Zhang, Zhenshu Xu, & Zhi-Zhe Chen. (2012). Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China. Oncology Letters, 5(4).

Chicago

Zhi-Hong Zheng, Shun-Quan Wu, Rong Zhan, Jin-Yan Zhang, Zhenshu Xu, and Zhi-Zhe Chen. 2012. “Younger Patients with Chronic Lymphocytic Leukemia Benefit from Rituximab Treatment: A Single Center Study in China.” Oncology Letters 5 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c5f6fac491dd6b3b5d89682943f393b1&authtype=sso&custid=ns315887.